Literature DB >> 11385134

Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy.

J Cederberg1, C M Simán, U J Eriksson.   

Abstract

The aim was to investigate whether dietary supplementation of a combination of the two antioxidants, vitamin E and vitamin C, would protect the fetus in diabetic rat pregnancy at a lower dose than previously used. Normal and streptozotocin-induced diabetic rats were mated and given standard food or food supplemented with either 0.5% vitamin E + 1% vitamin C or 2% vitamin E + 4% vitamin C. At gestational d 20, gross morphology and weights of fetuses were evaluated. Vitamins E and C and thiobarbituric acid reactive substances were measured in maternal and fetal compartments. In addition, protein carbonylation was estimated in fetal liver. Maternal diabetes increased the rate of malformation and resorption in the offspring. High-dose antioxidant supplementation decreased fetal dysmorphogenesis to near normal levels. The low-dose group showed malformations and resorptions at an intermediate rate between the untreated and the high-dose groups. Thiobarbituric acid reactive substances were increased in fetal livers of diabetic rats and reduced to normal levels already by low-dose antioxidative treatment. Protein carbonylation rate was also increased in fetal liver of diabetic rats; it was normalized by high-dose treatment but only partially reduced by low-dose antioxidants. We conclude that combined antioxidative treatment with vitamins E and C decreases fetal malformation rate and diminishes oxygen radical-related tissue damage. However, no synergistic effect between the two antioxidants was noted, a result that may influence future attempts to design antiteratogenic treatments in diabetic pregnancy. Oxidatively modified proteins may be teratogenically important mediators in diabetic embryopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385134     DOI: 10.1203/00006450-200106000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  36 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  Protecting the terminus: t-loops and telomere end-binding proteins.

Authors:  C Wei; M Price
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 3.  Maternal micronutrient restriction programs the body adiposity, adipocyte function and lipid metabolism in offspring: a review.

Authors:  K Rajender Rao; I J N Padmavathi; M Raghunath
Journal:  Rev Endocr Metab Disord       Date:  2012-06       Impact factor: 6.514

4.  Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects.

Authors:  Adolfo Correa; Suzanne M Gilboa; Lorenzo D Botto; Cynthia A Moore; Charlotte A Hobbs; Mario A Cleves; Tiffany J Riehle-Colarusso; D Kim Waller; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-12-27       Impact factor: 8.661

5.  Reduction in embryonic malformations and alleviation of endoplasmic reticulum stress by nitric oxide synthase inhibition in diabetic embryopathy.

Authors:  Zhiyong Zhao; Richard L Eckert; E Albert Reece
Journal:  Reprod Sci       Date:  2012-04-24       Impact factor: 3.060

6.  The spatio-temporal expression pattern of cytoplasmic Cu/Zn superoxide dismutase (SOD1) mRNA during mouse embryogenesis.

Authors:  Jung-Min Yon; In-Jeoung Baek; Se-Ra Lee; Yan Jin; Mi-Ra Kim; Sang-Seop Nahm; Jong-Soo Kim; Byeongwoo Ahn; Beom Jun Lee; Young Won Yun; Sang-Yoon Nam
Journal:  J Mol Histol       Date:  2007-09-05       Impact factor: 2.611

7.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

Review 8.  Modeling anterior development in mice: diet as modulator of risk for neural tube defects.

Authors:  Claudia Kappen
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

Review 9.  Diabetic embryopathy: a role for the epigenome?

Authors:  J Michael Salbaum; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-02

10.  Caudal dysgenesis in Islet-1 transgenic mice.

Authors:  Yunhua Li Muller; Yir Gloria Yueh; Paul J Yaworsky; J Michael Salbaum; Claudia Kappen
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.